Vir Biotechnology (VIR) Depreciation & Amortization (CF) (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 1.95% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $11.6 million (down 9.95% YoY), and the FY2025 full-year result was $11.7 million, down 19.77% from the prior year.
• Depreciation & Amortization (CF) slipped to $2.8 million in Q1 2026, from $2.9 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.6 million in Q1 2023 to a low of $1.4 million in Q1 2022.
• A 5-year average of $3.2 million and a median of $2.9 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) soared 297.32% in 2023 and tumbled 36.53% in 2025, its largest moves.
• Tracing VIR's Depreciation & Amortization (CF) over 5 years: stood at $2.4 million in 2022, then surged by 87.96% to $4.5 million in 2023, then slumped by 35.57% to $2.9 million in 2024, then rose by 0.42% to $2.9 million in 2025, then fell by 3.0% to $2.8 million in 2026.
• Business Quant data shows VIR's Depreciation & Amortization (CF) at $2.8 million in Q1 2026, $2.9 million in Q4 2025, and $3.0 million in Q3 2025.